Development of Convolutional Neural Networks to identify bone metastasis for prostate cancer patients in bone scintigraphy

被引:22
|
作者
Papandrianos, Nikolaos [1 ]
Papageorgiou, Elpiniki, I [1 ,3 ]
Anagnostis, Athanasios [2 ,3 ]
机构
[1] Univ Thessaly, Fac Technol, Dept Energy Syst, Geopolis Campus,Larissa Trikala Ring Rd, Larisa 41500, Greece
[2] Univ Thessaly, Comp Sci & Telecommun Dept, Lamia 35131, Greece
[3] Ctr Res & Technol Hellas, Inst Bioecon & Agritechnol, Thessaloniki, Greece
关键词
Bone metastasis; Prostate cancer; Nuclear imaging; Bone scintigraphy; Deep learning; Image classification; Convolutional Neural Networks; COMPUTER-AIDED DIAGNOSIS;
D O I
10.1007/s12149-020-01510-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective The main aim of this work is to build a robust Convolutional Neural Network (CNN) algorithm that efficiently and quickly classifies bone scintigraphy images, by determining the presence or absence of prostate cancer metastasis. Methods CNN, widely applied in medical image classification, was used for bone scintigraphy image classification. The retrospective study included 778 sequential male patients who underwent whole-body bone scans. A nuclear medicine physician classified all the cases into 3 categories: (1) normal, (2) malignant, and (3) degenerative, which were used as the gold standard. Results An efficient CNN architecture was built, based on CNN exploration performance, achieving high prediction accuracy. The results showed that the method is sufficiently precise when it comes to differentiating a bone metastasis from other either degenerative changes or normal tissue (overall classification accuracy = 91.42% +/- 1.64%). To strengthen the outcomes of this study the authors further compared the best performing CNN method to other popular CNN architectures for medical imaging, like ResNet50, VGG16 and GoogleNet, as reported in the literature. Conclusions The prediction results reveal the efficacy of the proposed CNN-based approach and its ability for an easier and more precise interpretation of whole-body images in bone metastasis diagnosis for prostate cancer patients in nuclear medicine. This leads to marked effects on the diagnostic accuracy and decision-making regarding the treatment to be applied.
引用
收藏
页码:824 / 832
页数:9
相关论文
共 50 条
  • [41] Heterogeneity of bone formation and resorption in prostate cancer bone metastasis
    Roudier, MP
    Coleman, IM
    True, LD
    Nelson, PS
    Ott, SM
    Higano, CS
    Vessella, RL
    CANCER TREATMENT REVIEWS, 2005, 31 : S28 - S29
  • [42] Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis
    Zhu Mingyue
    Liu Xin
    Qu Yuan
    Hu Silong
    Zhang Yingjian
    Li Wentao
    Zhou Xiaoyan
    Yang Huijuan
    Zhou Liangping
    Wang Qifeng
    Hou Yifeng
    Yong, Chen
    Wang Yanli
    Wang Yaohui
    Lu Zhongwu
    Luo Zhiguo
    Hu Xichun
    JOURNAL OF BONE ONCOLOGY, 2019, 15
  • [43] Clinical usefulness of bone markers in prostate cancer with bone metastasis
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Endo, Takumi
    Yano, Masashi
    Naoi, Makito
    Nishimi, Daisuke
    Kawamura, Koji
    Imamoto, Takashi
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (11) : 968 - 979
  • [44] Dissociation of bone formation markers in bone metastasis of prostate cancer
    M Koizumi
    H Maeda
    K Yoshimura
    T Yamauchi
    T Kawai
    E Ogata
    British Journal of Cancer, 1997, 75 : 1601 - 1604
  • [45] HEALTH CARE COSTS IN PATIENTS WITH BONE METASTASIS SECONDARY TO PROSTATE CANCER COMPARED TO PROSTATE CANCER PATIENTS WITHOUT BONE METASTASIS IN THE OPTUM ONCOLOGY RESEARCH DATABASE
    Seal, B.
    Valderrama, A.
    Xia, F.
    Shermock, K. M.
    Asche, C.
    VALUE IN HEALTH, 2013, 16 (03) : A190 - A190
  • [46] Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy
    Kadomoto, Suguru
    Yaegashi, Hiroshi
    Nakashima, Kazufumi
    Iijima, Masashi
    Kawaguchi, Shohei
    Nohara, Takahiro
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Kadono, Yoshifumi
    Nakajima, Kenichi
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2019, 39 (05) : 2553 - 2559
  • [47] Deep convolutional neural networks combine Raman spectral signature of serum for prostate cancer bone metastases screening
    Shao, Xiaoguang
    Zhang, Heng
    Wang, Yanqing
    Qian, Hongyang
    Zhu, Yinjie
    Dong, Baijun
    Xu, Fan
    Chen, Na
    Liu, Shupeng
    Pan, Jiahua
    Xue, Wei
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020, 29
  • [48] Evaluation of bone metastasis of castration-resistant prostate cancer after enzalutamide and abiraterone using Bone Scan Index on bone scintigraphy.
    Kadomoto, Suguru
    Izumi, Kouji
    Nohara, Takahiro
    Hiroyuki, Konaka
    Kadono, Yoshifumi
    Kitagawa, Yasuhide
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [49] Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer
    Wolff, JM
    Bares, R
    Jung, PK
    Buell, U
    Jakse, G
    UROLOGIA INTERNATIONALIS, 1996, 56 (03) : 169 - 173
  • [50] Predicting Bone Metastasis in Prostate Cancer Patients: Value of Prostate Specific Antigen
    Wei, Ling-Huei
    Chiu, Jainn-Shiun
    Chang, Shiou-Ying
    Wang, Yuh-Feng
    TZU CHI MEDICAL JOURNAL, 2008, 20 (04): : 291 - 295